ENPICOM secures more financing to extend data-driven antibody discovery
ENPICOM, an innovative bioinformatics software engineering company, has secured further financial backing from its current investors BOP Capital, BOM Brabant Ventures, Nextgen Ventures, and Arches Capital. This underscores investor confidence in ENPICOM’s vision, unique technological capabilities, and exceptional track record in serving customers in the pharmaceutical and biotech industries.
